Trulieve Cannabis Corp. (TCNNF) Insider Trading

Last 12 months

Insiders sold $14.7M and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Dec 2024.

Net open-market

−$14.7M

0 buys · 3 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Dec 2024

Dec 11, 2024

Get an email when TCNNF's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 26	Kim A. Rivers Chairman and CEO	Sold10b5-1 plan	136,811	$8.76	$1.2M	8.5%	Form 4
Jun 23 – 25	Kim A. Rivers Chairman and CEO	Sold10b5-1 plan 3 parts	1,080,000	$8.28 average	$8.94M	40%	Form 4
Jun 17 – 22	Kim A. Rivers Chairman and CEO	Sold10b5-1 plan 3 parts	482,196	$9.38 average	$4.53M	15%	Form 4
Dec 11, 2024	Wes Getman Chief Financial Officer	Bought	9,500	$4.91	$47k	25%	Form 4
Nov 21, 2024	Richard S. May Director	Bought	1,610	$6.05	$10k	0.3%	Form 4
Nov 21, 2024	Peter Healy Director	Bought	8,130	$6.05	$49k	36%	Form 4
Nov 21, 2024	Jane C Morreau Director	Bought	1,235	$6.06	$7k	5.5%	Form 4
Nov 21, 2024	Richard S. May Director	Bought	1,160	$6.05	$7k	0.2%	Form 4
Nov 20, 2024	Susan Thronson Director	Bought	3,968	$6.30	$25k	8.5%	Form 4
Nov 20, 2024	Susan Thronson Director	Bought	3,968	$6.30	$25k	14%	Form 4
Nov 19, 2024	Thomas L Millner Director	Bought	8,000	$6.12	$49k	36%	Form 4
Nov 15, 2024	Thad Beshears Director	Bought	7,500	$6.65	$50k	0.3%	Form 4
Nov 15, 2024	Kim A. Rivers Chairman and CEO	Bought	7,400	$6.65	$49k	0.4%	Form 4
Nov 13, 2024	Eric Powers Chief Legal Officer	Bought	1,000	$6.10	$6k	0.8%	Form 4
Nov 12, 2024	Gina Collins Chief Marketing Officer	Bought	1,250	$6.37	$8k	1.2%	Form 4
Nov 8, 2024 – Nov 12, 2024	Nilyum Jhala Chief Technology Officer	Bought 3 parts	6,000	$6.28 average	$38k	5.2%	Form 4
Nov 11, 2024	Kyle Landrum Chief Production Officer	Bought 2 parts	3,800	$6.50 average	$25k	2.9%	Form 4
Nov 8, 2024	Marie Zhang Chief Operating Officer	Bought	21,300	$7.19	$153k	57%	Form 4

Jun 2610b5-1 plan
Kim A. Rivers
Chairman and CEO · sold 136,811 at $8.76
$1.2M
8.5% of stake
Jun 23 – 2510b5-1 plan
Kim A. Rivers
Chairman and CEO · sold 1,080,000 at avg $8.28
$8.94M
40% of stake
Jun 17 – 2210b5-1 plan
Kim A. Rivers
Chairman and CEO · sold 482,196 at avg $9.38
$4.53M
15% of stake
Dec 11, 2024
Wes Getman
Chief Financial Officer · bought 9,500 at $4.91
$47k
25% of stake
Nov 21, 2024
Richard S. May
Director · bought 1,610 at $6.05
$10k
0.3% of stake
Nov 21, 2024
Peter Healy
Director · bought 8,130 at $6.05
$49k
36% of stake
Nov 21, 2024
Jane C Morreau
Director · bought 1,235 at $6.06
$7k
5.5% of stake
Nov 21, 2024
Richard S. May
Director · bought 1,160 at $6.05
$7k
0.2% of stake
Nov 20, 2024
Susan Thronson
Director · bought 3,968 at $6.30
$25k
8.5% of stake
Nov 20, 2024
Susan Thronson
Director · bought 3,968 at $6.30
$25k
14% of stake
Nov 19, 2024
Thomas L Millner
Director · bought 8,000 at $6.12
$49k
36% of stake
Nov 15, 2024
Thad Beshears
Director · bought 7,500 at $6.65
$50k
0.3% of stake
Nov 15, 2024
Kim A. Rivers
Chairman and CEO · bought 7,400 at $6.65
$49k
0.4% of stake
Nov 13, 2024
Eric Powers
Chief Legal Officer · bought 1,000 at $6.10
$6k
0.8% of stake
Nov 12, 2024
Gina Collins
Chief Marketing Officer · bought 1,250 at $6.37
$8k
1.2% of stake
Nov 8, 2024 – Nov 12, 2024
Nilyum Jhala
Chief Technology Officer · bought 6,000 at avg $6.28
$38k
5.2% of stake
Nov 11, 2024
Kyle Landrum
Chief Production Officer · bought 3,800 at avg $6.50
$25k
2.9% of stake
Nov 8, 2024
Marie Zhang
Chief Operating Officer · bought 21,300 at $7.19
$153k
57% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch TCNNF, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Medicinal Chemicals & Botanical Products

USNAUsana Health Sciences, Inc.

TLRYTilray Brands, Inc.

AAWHAscend Wellness Holdings, Inc.

CGCCanopy Growth Corporation

JUSHFJushi Holdings Inc.

BTMDBiote Corp.

CRONCronos Group Inc.

MRMDMariMed Inc.

Spot a number that looks wrong? Check it in TCNNF's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing TCNNF

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.